Healthcare News and Headlines
Healthcare News and Headlines
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
Insilico Medicine, a veteran AI‑driven drug discovery firm, announced a partnership with Eli Lilly that includes a $115 million upfront payment and up to $2.75 billion in milestone‑based total consideration. The deal leverages Insilico’s generative‑AI platform to co‑develop novel therapeutics, primarily targeting metabolic diseases. Insilico’s CEO emphasized a pragmatic AI philosophy that blends deep learning with traditional pharmacology to shorten timelines and improve hit rates. The collaboration marks one of the largest AI‑centric contracts in biotech to date.
Eleven early‑stage life‑sciences startups were chosen for the Drive accelerator, with eight headquartered in Massachusetts and the remaining three in South Carolina. MassBio will manage the biotech cohort while SCbio leads the biomarkers and diagnostics group. The free eight‑week program...
U.S. remains the only OECD nation without a national paid family and medical leave (PFML) system, prompting many states to adopt either comprehensive PFML programs or voluntary private‑insurance models. While 13 states and Washington, D.C. have enacted universal PFML laws...
Claiborne Memorial Medical Center in rural Louisiana launched a pilot program that enrolls 22 high‑risk patients in remote patient monitoring (RPM) to supplement its chronic‑care model. By transmitting home‑collected vitals such as blood pressure and glucose readings, clinicians can adjust...
The ROBO Global Healthcare Technology & Innovation Index (HTEC) offers investors a research‑driven way to capture disruptive health‑tech across nine subsegments, from robotics to genomics. It moves beyond traditional pharmaceutical or provider classifications by scoring companies on revenue from innovative...
Automation, AI, and advanced analytics have moved from optional tools to core components of the healthcare revenue cycle. By targeting repetitive, high‑volume tasks across front‑end eligibility checks, mid‑cycle documentation, and back‑end claims processing, organizations can cut errors, lower denial rates,...
New York is confronting a deepening behavioral health crisis, with suicide rates climbing more than 40% over the past 20 years and overdose deaths nearly four times higher than in 2010. Medicaid Managed Care Organizations have extracted hundreds of millions...
Employers are confronting the steepest premium hikes in 15 years, with average family coverage nearing $25,500 and a 10% increase this year. The article argues that the employer‑based insurance model’s built‑in barriers—prior authorizations, narrow networks, and opaque pricing—are features, not...
A recent JAMA Network Open study found that older women with elevated plasma phosphorylated tau 217 (p‑tau217) face a significantly higher chance of developing mild cognitive impairment or dementia up to 25 years later. The biomarker offers clinicians a window for early...
Q1 2026 biopharma saw a wave of mega‑size M&A, with deals like Boston Scientific’s $14.5 billion purchase of Penumbra and Eli Lilly’s $7.8 billion acquisition of Centessa, underscoring a strategic push for precision platforms. The quarter also delivered a string of rare‑disease approvals—Zycubo,...
Individual Coverage Health Reimbursement Arrangements (ICHRA) are shedding their niche label as large enterprises adopt them to tackle soaring health‑care costs, fragmented workforces, and employee demand for personalized benefits. By converting open‑ended premiums into a fixed employer contribution, ICHRAs give...
Pharmacierge, the UK’s leading private e‑prescription and medication delivery platform, has partnered with luxury magazine Tatler to launch the annual Tatler Doctors Guide, highlighting the nation’s top private clinicians. The guide, compiled with input from more than 45 private GPs...
Surgeons are overwhelmed by isolated devices that generate data without context, creating a hidden cognitive burden in the operating room. The industry is shifting from a hardware‑centric model to integrated platforms that synthesize information in real time, mirroring aviation’s move...
Water flossers, also known as oral irrigators, have become a common fixture in American bathrooms since their commercial debut in the 1960s. Dental experts, including UCSF’s Dr. Diana Nguyen, endorse them as a useful adjunct for patients who struggle with...
Benign prostatic hyperplasia (BPH) affects nearly half of men over 50 and up to 90% of those over 80, causing urinary urgency, weak flow, and nocturia that erode quality of life. While lifestyle changes and alpha‑blockers can manage mild cases,...
At the American College of Cardiology 2026 meeting, researchers reported that dulaglutide, a weekly GLP‑1 receptor agonist, stabilised coronary plaques in patients with type‑2 diabetes. In a prospective randomised trial of 39 participants with intermediate coronary stenoses, dulaglutide led to...
Vaccines prove their worth when they fail, as recent flu and COVID‑19 seasons have shown. The COVID‑19 pandemic exposed how quickly a novel virus can outpace vaccine development, while the 2025 flu season suffered a mismatch when the H 3 N 2 strain...
A coalition of nearly 100 rare‑disease patient groups, biotech executives and investors wrote to President Trump, Health Secretary Robert F. Kennedy Jr., Medicare administrator Mehmet Oz and FDA Commissioner Marty Makary urging the administration to restore regulatory clarity at the...
A retrospective cohort of 734 patients with atrial fibrillation and heart failure with preserved ejection fraction found that a higher prognostic nutritional index (PNI) was independently associated with lower rates of major adverse cardiovascular events (MACE) and all‑cause mortality over...
A multicenter cross‑sectional study of 4,503 newly admitted adult patients across 23 hospitals in Jiangsu Province found that 24.9% had borderline‑elevated or elevated total cholesterol. Prevalence was higher in women (28.7%) than men (22.1%) and peaked at 31.6% among those...
Hospital spending drives U.S. health‑care cost growth, accounting for roughly one‑third of total expenditures and 41 % of the increase between 2022 and 2024. Prices for hospital services have surged about 250 % since 2000, outpacing inflation and other sectors such as...
Danish biotech IO Biotech announced it will wind down operations and file for Chapter 7 bankruptcy after regulatory setbacks. The FDA rejected its biologics license application for the cancer vaccine Cylembio in September, citing insufficient data. A Phase 3 trial combining Cylembio...
The National Coalition for Hospice and Palliative Care (NCHPC) has appointed a 33‑member expert panel to draft the fifth edition of its Clinical Practice Guidelines for Quality Palliative Care. First released in 2004, the guidelines set national, evidence‑based standards across...
The Centers for Medicare & Medicaid Services (CMS) has drafted rules that would allow non‑network, indemnity‑style health plans to be classified as major medical coverage on the 2027 ACA exchanges. If approved, these plans could qualify for premium tax credits,...
Payviders—insurers that also own provider assets—are reshaping hospice partnerships, with Humana, UnitedHealth and emerging player SCAN Group leading the trend. These entities integrate Medicare Advantage plans, home‑care subsidiaries and primary‑care clinics to create vertically aligned networks. Hospices must adapt to...
In a recent interview, licensed clinical social worker William Dempsey discusses the surge in LGBTQ self‑identification, now estimated at 9.3% of U.S. adults, and attributes it to generational change, internet‑driven language, and greater mental‑health access. He explains how internalized stigma...
Medical device makers face rising production demands, labor shortages, and tighter regulatory scrutiny, turning automation from a tactical upgrade into a strategic imperative. Integrion Automation argues that automation must be embedded in an integrated operational strategy that delivers repeatable precision,...
Medical Design Briefs released a series of April 2026 podcasts spotlighting emerging drug‑delivery trends. Episodes feature First Ascent Biomedical’s AI‑driven platform that personalizes oncology therapy, MGS engineers discussing greener insulin‑pen designs, RenovoRx’s intra‑arterial delivery system that targets solid tumors, and...
The Wohlers Report 2026 declares additive manufacturing has entered an "Era of Industrial Mastery," as hardware sales plateau and firms shift focus to utilization. High‑interest rates are tightening capital discipline, prompting medical device companies to extract more value from existing...
A novel glioblastoma treatment combining oral 5‑ALA with low‑intensity ultrasound has shown promising early results, extending median survival by over 14 months in a phase 1 trial for recurrent patients. The approach sensitizes tumor cells to ultrasound, allowing diffuse targeting of...
One year after the Trump administration’s sweeping HHS layoffs, the FDA’s Center for Devices and Radiological Health (CDRH) is grappling with severe understaffing and morale issues. Between September 2024 and January 2026 the agency shed roughly 21 % of its workforce—over 4,400 employees—leaving...
UC San Diego engineers have created a battery‑free electronic sticker that attaches to drinking cups and measures a user’s vitamin C levels from fingertip sweat. The biofuel cell harvests sweat‑derived electricity to power a hydrogel‑based sensor, which wirelessly sends results to...
The FDA’s leadership turmoil has intensified under Commissioner Marty Makary, with the agency cycling through multiple heads of its CDER and CBER centers in just over a year. Public‑facing comments from senior officials have sparked sharp stock moves, most notably...
MIT and Microsoft researchers unveiled CleaveNet, an AI system that designs peptide sensors targeting cancer‑linked proteases. The model rapidly generates highly specific sequences, cutting the design time from months to minutes and slashing experimental costs. Coated nanoparticles release cleaved peptides...
Pfizer and French partner Valneva are seeking FDA approval for a 6‑valent OspA Lyme disease vaccine after a late‑stage trial showed more than 70% efficacy, though the study missed its primary statistical endpoint due to low infection rates. The candidate...
Mike Moore, JeffSTAT lead pilot for Air Methods, completed his 3,000th patient transport in March, a milestone reached by few air‑medical pilots. The achievement caps an 18‑year tenure at the Lansdale base and reflects over 7,750 total flight hours, including...
GlaxoSmithKline’s biologic Exdensur (depemokimab) received approval from China’s National Medical Products Administration as an add‑on maintenance therapy for patients aged 12 and older with severe eosinophilic asthma. The approval is based on Phase III SWIFT‑1 (382 participants) and SWIFT‑2 (380 participants)...
Mitsubishi Chemical Group has launched ChronoFlex S, a 60A thermoplastic polyurethane that delivers silicone‑like softness while retaining the superior tensile strength and abrasion resistance of TPU. The material contains 36% USDA‑certified biobased content and can be processed by melt, extrusion, injection...
Amesbury’s City Council approved a $14,858 grant from the Massachusetts Interlocal Insurance Association to fund cardiac screenings for 17 of the fire department’s 39 members. The grant, secured by Lieutenant David Carpentier, will cover expensive heart‑health evaluations scheduled for late...
Oric Pharmaceuticals announced that its PRC2 inhibitor will move into a registrational Phase 3 trial for prostate cancer after reporting encouraging safety and disease‑control signals in a Phase 1b study. The company plans to evaluate the drug both as a...
The Government Accountability Office identified that the Department of Health and Human Services obligated at least $34 million in federal grants to 16 crisis pregnancy centers (CPCs) between fiscal years 2018 and 2024. CPCs, typically nonprofit and faith‑based, offer free or...
Frontier Medicines has granted LG Chem an exclusive global license to develop and commercialize its covalent p53 Y220C activator FMC-220 outside Greater China, while retaining full rights within that region. LG Chem will manage regulatory filings, global clinical development, and...
The World Health Organization released new guidelines that introduce near point‑of‑care nucleic acid amplification tests, tongue‑swab specimens, and sputum pooling to speed and broaden TB diagnosis. These tools aim to shift testing to primary‑care settings, lower costs, and improve throughput...
The 988 Lifeline, the nation’s 24‑hour free suicide‑prevention service, has fielded roughly 25 million contacts since its launch in July 2022. Autistic individuals, who are significantly more likely to experience suicidal thoughts, often encounter communication barriers that can turn a crisis call...
Researchers reviewed pre‑clinical studies and performed molecular‑docking simulations to assess resveratrol’s interaction with ovarian cancer proteins. The analysis suggests the antioxidant may modulate cell growth, inflammation, hormone signaling, and stress pathways, potentially enhancing the efficacy of chemotherapy and radiation. While...
Patients Know Best teamed with Heartfelt Technologies to automate recruitment for the Innovate UK‑funded HF‑TRACK trial, enrolling 16 participants in just four weeks—a 135% increase over the trial’s average rate. The partnership leveraged PKB’s coded health‑record data to display a...
High‑acuity neurological care is grappling with massive data streams and fragmented handoffs, prompting a push for AI‑driven decision support and unified digital pathways. Machine‑learning models now analyze multimodal ICU inputs to flag early deterioration and streamline imaging interpretation. Yet the...
Ocular Therapeutix (OCUL) received upgraded price targets from Bank of America and Clear Street, raising them to $27 and $28 respectively while maintaining Buy ratings. Both firms highlighted the Phase 3 SOL‑1 trial, which demonstrated durable control of wet age‑related macular...
The global wearable AI devices market is projected to surge from $69.8 billion in 2026 to about $270.2 billion by 2036, delivering a 14.5% compound annual growth rate. Smartwatches dominate the market today, while eye‑wear is set to post the fastest growth...
GLP‑1 drugs such as Ozempic and Wegovy are prompting measurable changes in grocery purchasing patterns. A Danish study of 1,177 adults, covering nearly two million transactions, found that users bought foods with slightly lower calories, sugar, carbohydrates and saturated fat,...
